Evidence map›Paper›PMID 39606531›Full record

ReviewCureus2024

Using the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Markers for Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis of Observational Studies.

Mahmoud Mohamed Attia, Mohammad Alameen Qasim, Hamzeh Samer Alhamwi, Mahmoud Ali, Ebtihal Abdelhay Alsharief, Judy Sobhy Ali, Mohamed Elmasry, Ahmed Elgebaly, Eshak I Bahbah

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mahmoud Mohamed AttiaFaculty of Medicine, Al-Azhar University, Damietta, EGY.
Mohammad Alameen QasimDepartment of Clinical Pharmacy, Al-Emamin Al-Kadhimeen City Teaching Hospital, Baghdad, IRQ.
Hamzeh Samer AlhamwiFaculty of Pharmacy, Philadelphia University, Amman, JOR.
Mahmoud AliFaculty of Medicine, Al-Azhar University, Damietta, EGY.
Ebtihal Abdelhay AlshariefFaculty of Pharmacy, Cairo University, Cairo, EGY.
Judy Sobhy AliFaculty of Medicine, Cairo University, Cairo, EGY.
Mohamed ElmasryFaculty of Medicine, Alexandria University, Alexandria, EGY.
Ahmed ElgebalySmart Health Centre, University of East London, London, GBR.
Eshak I BahbahFaculty of Medicine, Al-Azhar University, Damietta, EGY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnea (OSA) is a chronic condition characterized by the partial or complete collapse of the airways during sleep, leading to hypoxemia (reduced oxygen flow to organs) and disrupted sleep. This study aims to establish robust evidence for the relationship between the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) and the severity and prognosis of OSA. A systematic review and meta-analysis were conducted using PubMed, Cochrane Central Register of Controlled Trials, Scopus, Medline, and Web of Science to gather all relevant articles. Twenty-six eligible articles were included in the study. The pooled outcomes indicated that the NLR and PLR were significantly higher in patients with OSA compared to controls. Subgroup analyses based on the severity of OSA showed that differences in the NLR were more pronounced in patients with severe OSA. Moreover, meta-regression analysis revealed that variations in mean age, BMI, and male proportion did not significantly affect the differences in the NLR and PLR. OSA has a significant impact on NLR and PLR levels, making them useful markers for detecting the inflammatory status in OSA patients.

Indexed as

diagnostic biomarkersneutrophil-to-lymphocyte ratioobstructive sleep apneaplatelet-to-lymphocyte ratioprognostic biomarkers

Identifiers

PMID39606531
PMCPMC11600666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.